PlateletDiagnostics Announces Novel Immune-Based Platelet Function Assay to Monitor Antiplatelet Therapy
PlateletDiagnostics, LLC, based in Watertown, Mass., revealed on April 6, 2026, the creation of a pioneering platelet function assay. This assay assesses the phosphorylation of the plentiful platelet protein, dynamin-related protein 1 (Drp1), through a straightforward ELISA method.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments